Showing 921 - 933 results of 933 for search '"rheumatologist"', query time: 0.10s Refine Results
  1. 921

    OPTIMIZING THE DIAGNOSIS, A MONITORING AND TREATMENT SYSTEM FOR PSORIATIC ARTHRITIS IN REAL PRACTICE: GENERAL PRINCIPLES FOR ORGANIZING AN ALL-RUSSIAN REGISTER OF PATIENTS WITH PSO... by T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, A. D. Koltakova, E. E. Medved, S. S. Kudishina, A. V. Petrov, M. V. Sedunova, I. N. Pristavsky, E. A. Vasilenko, I. N. Bondareva, I. F. Umnova, P. A. Shesternya, E. L. Nasonov

    Published 2019-09-01
    “…Nasonova Research Institute of Rheumatology and with the support of the All-Russian public organization «Association of Rheumatologists of Russia». This system is an all-Russian population-based register that allows for the recording and monitoring of patients with PsA throughout the follow-up period. …”
    Get full text
    Article
  2. 922
  3. 923

    Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis – a prospective multicenter cohort s... by Josefine M. Halbig, Birgitta Jönsson, Elisabeth G. Gil, Anne N. Åstrøm, Veronika Rypdal, Paula Frid, Thomas A. Augdal, Johannes Fischer, Lena Cetrelli, Marite Rygg, Anette Lundestad, Karin Tylleskär, Ellen Nordal, For the Norwegian JIA Study – Temporo-mandibular Involvement, Oral Health, Uveitis, Bone Health, Quality of Life in Children with Juvenile Idiopathic Arthritis

    Published 2023-11-01
    “…Conclusions Children and adolescents with orofacial pain or impaired physical health were more likely to report impacts on daily life activities than those without. Pediatric rheumatologists and dentists should be aware of impaired OHRQoL in individuals with JIA with active disease or temporomandibular joint involvement. …”
    Get full text
    Article
  4. 924
  5. 925

    Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPA... by Francesco Bozzao, Paola Tomietto, Elisa Baratella, Metka Kodric, Rossella Cifaldi, Rossana Della Porta, Ilaria Prearo, Silvia Maria Grazia Pirronello, Paola Confalonieri, Barbara Ruaro, Fabio Fischetti, Bruno Fabris

    Published 2023-04-01
    “…<i>Methods:</i> We retrospectively evaluated data on 133 consecutive patients with ILD at onset associated with at least one feature of autoimmunity, referred by pulmonologists to rheumatologists from March 2009 to March 2020. Patients received 33 (16.5–69.5) months of follow-up. …”
    Get full text
    Article
  6. 926

    Oral health-related quality of life in 4–16-year-olds with and without juvenile idiopathic arthritis by Elisabeth G. Gil, Marit S. Skeie, Josefine Halbig, Birgitta Jönsson, Stein Atle Lie, Marite Rygg, Johannes Fischer, Annika Rosén, Athanasia Bletsa, Keijo Luukko, Xie-Qi Shi, Paula Frid, Lena Cetrelli, Karin Tylleskär, Karen Rosendahl, Anne N. Åstrøm

    Published 2022-09-01
    “…JIA-specific characteristics were assessed by pediatric rheumatologists and socio-demographic, behavioral and self-reported oral health information collected by questionnaires. …”
    Get full text
    Article
  7. 927

    A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT... by L. I. Alekseeva, E. P. Sharapova, E. A. Taskina, N. V. Chichasova, G. R. Imametdinova, N. A. Shostak, N. G. Pravdyuk, L. N. Denisov

    Published 2014-06-01
    “…The study included 90 patients with knee OA (according to the criteria of the Russian Association of Rheumatologists) at the stage 2–3 (according to the Kellgren-Lawrence scale); pain score when walk- ing ≥ 40 mm (assessed using the visual analog scale). …”
    Get full text
    Article
  8. 928
  9. 929

    Combining Traditional Chinese Herbs and csDMARDs for the Treatment of Rheumatoid Arthritis Involves Tapering and Discontinuing Glucocorticoids: Protocol for a Two-Stage Non-Randomi... by Wang X, Yang X, Wang S, Tian X, Yin J, Liu N, Di P, Qi J, Li Y, Chen J, Wu Y, Wu J, Zhao W, Peng J, Zhang L, Gu L

    Published 2024-03-01
    “…Xingqiang Wang,1,2,&ast; Xianna Yang,3,&ast; Shiqi Wang,3,&ast; Xiaofang Tian,1 Jianmei Yin,3 Nian Liu,3 Pengtao Di,1 Jipeng Qi,3 Ya Li,3 Jimin Chen,3,4 Yang Wu,1 Jingjin Wu,1,2 Weiqing Zhao,5 Jiangyun Peng,1,2 Ling Zhang,1,2 Lingli Gu1 1Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China; 2Yunnan Provincial Clinical Medicine Research Center of Rheumatism in TCM, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China; 3The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China; 4Department of Integrative Internal Medicine, The Lijiang Hospital of Traditional Chinese Medicine, Lijiang, Yunnan, 674100, People’s Republic of China; 5Department of Rheumatology and Immunology, The First People’s Hospital of Yunnan Province and The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, 650034, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Ling Zhang; Lingli Gu, Email zebaiyuan@126.com; guyuxin82@126.comAbstract: Glucocorticoids (GC) are crucial in the treatment of rheumatoid arthritis (RA), but discontinuing GC effectively in RA patients poses a significant challenge for rheumatologists. In this two-stage, single-center, non-randomized controlled trial, we investigated the benefits of combining Chinese traditional herbal treatment with csDMARDs to aid GC discontinuation in terms of GC tapering, disease control, and safety. …”
    Get full text
    Article
  10. 930

    Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease by Matthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, Martin G. Pomper, Steven P. Rowe, Marc Schmalzing, Hans-Peter Tony, Michael Gernert, Patrick-Pascal Strunz, Jan Portegys, Eva-Christina Schwaneck, Ottar Gadeholt, Alexander Weich, Andreas K. Buck, Thorsten A. Bley, Konstanze V. Guggenberger, Rudolf A. Werner

    Published 2021-11-01
    “…Prior to [<sup>18</sup>F]FDG PET/CT, 22/34 (64.7%) of patients did not have an established diagnosis, whereas in 7/34 (20.6%), polymyalgia rheumatica (PMR) was suspected, and in 5/34 (14.7%), giant cell arteritis (GCA) was suspected by the referring rheumatologists. After [<sup>18</sup>F]FDG PET/CT, the diagnosis was GCA in 19/34 (55.9%), combined GCA and PMR (GCA + PMR) in 9/34 (26.5%) and PMR in the remaining 6/34 (17.6%). …”
    Get full text
    Article
  11. 931

    The Debut of Inflammatory Musculoskeletal Pathology in Patients Receiving Anticancer Therapy with PD-1/PD-L1 Pathway Inhibitors by A. D. Koltakova, A. M. Lila, O. G. Alekseeva, A. A. Fedenko, Y. V. Gridneva, A. S. Olshanskaya

    Published 2022-10-01
    “…Additional studies and close cooperation between rheumatologists and oncologists are needed to obtain a more complete understanding of the nature and spectrum of musculoskeletal AEs, to identify their clinical, laboratory and instrumental features, and to develop an management of patients algorithm.…”
    Get full text
    Article
  12. 932
  13. 933